Browse All
Displaying 6 - 6 of 6
Author:Giovannoni, Gavin Leist, Thomas Jack, Dominic Galazka, Andrew Nolting, Axel
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.010
Author Institution:Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom Ares Trading S.A., Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany